|
Published by: Millennium Research
Published: Mar. 22, 2007
Table of Contents
- LIST OF EXHIBITS
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 ORTHOPEDIC BIOMATERIALS MARKET
- 1.1 Market Overview
- 1.2 Overview of Orthopedic Biomaterials
- 1.3 Pharmaceutical Affairs Law
- 1.4 Market Analysis
- 1.5 Competitive Analysis
- 1.5.1 Leading Competitors
- 2.0 HYALURONIC ACID VISCOSUPPLEMENTATION
- 2.1 Market Overview
- 2.2 Osteoarthritis and Rheumatoid Arthritis
- 2.2.1 Osteoarthritis Overview
- 2.2.2 Rheumatoid Arthritis Overview
- 2.3 Overview of Hyaluronic Acid Viscosupplementation
- 2.4 Market Analysis
- 2.4.1 Treatments
- 2.4.2 Market Forecast
- 2.4.3 Market Drivers and Limiters
- 2.4.3.1 Market Drivers
- 2.4.3.2 Market Limiters
- 2.4.3.3 Market Trends
- 2.5 Competitive Analysis
- 2.5.1 Leading Competitors
- 2.5.2 Emerging Competitors
- 3.0 BONE GRAFT SUBSTITUTE MARKET
- 3.1 Market Overview
- 3.2 Bone Grafting Overview
- 3.2.1 Autograft
- 3.2.2 Allograft
- 3.2.3 Synthetic Bone
- 3.2.4 Growth Factors
- 3.3 Market Analysis
- 3.3.1 Procedures
- 3.3.1.1 By Material
- 3.3.1.2 By Indication
- 3.3.2 Market Forecast
- 3.3.3 Market Drivers and Limiters
- 3.3.3.1 Market Drivers
- 3.3.3.2 Market Limiters
- 3.4 Competitive Analysis
- 3.4.1 Leading Competitors
- APPENDIX A: ACRONYMS AND INITIALISMS
- MRG List of Exhibits
- EXECUTIVE SUMMARY
- Exhibit ES-1: Orthopedic Biomaterials Market, by Segment, as a % ofTotal, Japan, 2006 and 2011
- Exhibit ES-2: HA Injections, Japan, 2006 and 2011
- Exhibit ES-3: BGS Procedures, by Indication, Japan, 2006
- METHODOLOGY
- Exhibit M-1: Currency Exchange Rates, 2006
- CHAPTER 1: ORTHOPEDIC BIOMATERIALS MARKET
- Exhibit 1-1: Orthopedic Biomaterials Market, Japan (US$), 2005-2011
- Exhibit 1-2: New Categorization of Medical Devices
- Exhibit 1-3: Orthopedic Biomaterials Market, by Segment, Japan (US$),2005-2011
- Exhibit 1-4: Orthopedic Biomaterials Market, by Segment, Japan (¥),2005-2011
- Exhibit 1-5: Leading Competitors in the Orthopedic Biomaterials Market,Japan, 2006 (Tabular Format)
- Exhibit 1-6: Leading Competitors in the Orthopedic Biomaterials Market,Japan, 2006 (Graphical Format)
- CHAPTER 2: HYALURONIC ACID VISCOSUPPLEMENTATION
- Exhibit 2-1: HA Viscosupplementation Market, Japan (US$), 2005-2011
- Exhibit 2-2: HA Treatments and Injections, Japan, 2005-2011
- Exhibit 2-3: HA Injection Market, Japan (US$), 2005-2011
- Exhibit 2-4: HA Injection Market, Japan (¥), 2005-2011
- Exhibit 2-5: Drivers, Limiters, and Trends of the HAViscosupplementation Market, Japan
- Exhibit 2-6: Over-65 Cohort as a % of Total Population, Europe, Japan,and US, 2005-2050
- Exhibit 2-7: Diagnosed Arthritis Sufferers, Japan, 2006
- Exhibit 2-8: Leading Competitors in the HA ViscosupplementationMarket, Japan, 2006
- CHAPTER 3: BONE GRAFT SUBSTITUTE MARKET
- Exhibit 3-1: BGS Market, Japan (US$), 2005-2011
- Exhibit 3-2: Characteristics of Bone Graft Materials
- Exhibit 3-3: Advantages and Disadvantages of Various Bone GraftMaterials
- Exhibit 3-4: Types of Synthetic BGS Materials
- Exhibit 3-5: Bone Graft Procedures, by Material, Japan, 2005-2011
- Exhibit 3-6: Synthetic BGS Procedures, by Indication, Japan, 2005-2011
- Exhibit 3-7: Synthetic BGS Market, Japan (US$), 2005-2011
- Exhibit 3-8: Synthetic BGS Market, Japan (¥), 2005-2011
- Exhibit 3-9: Synthetic BGS Market, by Indication, Japan (US$), 2005-2011
- Exhibit 3-10: Synthetic BGS Market, by Indication, Japan (¥), 2005-2011
- Exhibit 3-11: Trauma Synthetic BGS Market, Japan (US$), 2005-2011
- Exhibit 3-12: Trauma Synthetic BGS Market, Japan (¥), 2005-2011
- Exhibit 3-13: Spine Synthetic BGS Market, Japan (US$), 2005-2011
- Exhibit 3-14: Spine Synthetic BGS Market, Japan (¥), 2005-2011
- Exhibit 3-15: Joint Reconstruction Synthetic BGS Market, Japan (US$),2005-2011
- Exhibit 3-16: Joint Reconstruction Synthetic BGS Market, Japan (¥),2005-2011
- Exhibit 3-17: CMF Synthetic BGS Market, Japan (US$), 2005-2011
- Exhibit 3-18: CMF Synthetic BGS Market, Japan (¥), 2005-2011
- Exhibit 3-19: Drivers and Limiters of the BGS Market, Japan
- Exhibit 3-20: Leading Competitors in the BGS Market, Japan, 2006
AbstractThe Japanese orthopedic biomaterials market is comprised of bone graft substitutes and hyaluronic acid injections for viscosupplementation.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|